FT商學院

Trump’s drug price treatment is harsh but justified
Lex專欄:川普重拳出擊美國藥價是合理之舉

The US is the biggest market for prescription drugs, accounting for roughly $600bn of annual sales out of a global $1tn or so
2022年美國藥品的名義價格是33個經合組織國家對比組平均水準的2.8倍。

“You get what you pay for” has a nice ring to it. But it does not accurately describe the situation of those buying prescription pharmaceuticals in the US. President Trump, who has vowed to lower drugs prices by as much as 80 per cent, may finally have found a useful target for his sledgehammer. 

「一分錢一分貨」這句話說得恰如其分。但這並不能準確描述美國處方藥購買者的處境。美國總統川普發誓要將藥價降低最多80%,他可能終於爲他的大錘找到了一個有用的靶子。

您已閱讀10%(378字),剩餘90%(3547字)包含更多重要資訊,訂閱以繼續探索完整內容,並享受更多專屬服務。
版權聲明:本文版權歸FT中文網所有,未經允許任何單位或個人不得轉載,複製或以任何其他方式使用本文全部或部分,侵權必究。
設置字型大小×
最小
較小
默認
較大
最大
分享×